Over expression of SPARC promoted GC progression, including serosal invasion, lymph node, and distant metastasis, and tended to poor prognosis of patients (Zhao et al., 2010; Sato et al., 2013; Wang et al., 2014). Here, SPARC is linked to gastric cancer.